Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2dc9a78dd4b3a699238d6c136eab8d02 |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-54 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-55561 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-39 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-7115 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0019 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-39 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-435 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61N5-00 |
filingDate |
2020-10-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_073f9d808d98b02d8e5c762c89db3b1f http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b8159d6764be3fb66ee8ea9f3304b64e http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_61ed4a26ccf4390db0b5f2bfbafbbb27 |
publicationDate |
2021-01-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
AU-2020250293-A1 |
titleOfInvention |
Treatment of cancer using TLR9 agonist with checkpoint inhibitors |
abstract |
TREATMENT OF CANCER USING TLR9 AGONIST WITH nCHECKPOINT INHIBITORS nABSTRACT nThe invention provides methods of inducing an immune response to cancer comprising conadministering to a cancer patient one or more TLR9 agonists and one or more checkpoint ninhibitors. Preferably, the one or more TLR9 agonists are administered to the patient via nintratumoral (i.t.) administration. |
priorityDate |
2014-10-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |